Related Experiment Video
Updated: Feb 5, 2026

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
In Vivo Evaluation of Dystrophin Exon Skipping in mdx Mice
Bo Wu1, Mingxing Wang2, Sapana Shah2
1McColl-Lockwood Laboratory for Muscular Dystrophy Research, Department of Neurology, Neuromuscular/ALS Center, Carolinas Medical Center, Charlotte, NC, USA. bo.wu@carolinashealthcare.org.
Abstract:
Dystrophin exon skipping in mdx mice has been the key model for the development of antisense therapy in vivo. Evaluation of exon skipping in this model involves the following two aspects: (1) efficiency and accuracy of exon skipping and levels of dystrophin expression determined by RT-PCR, immunochemistry, and western blotting; (2) therapeutic effects on muscle pathology and functions assessed by histology and functional assays including grip strength measurement, treadmill test, echocardiogram, and hemodynamics for cardiac functions. Here we describe some key considerations and the essential methodologies in detail for exon skipping in mdx mice.
Related Concept Videos
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Self-Evaluation: Self-Enhancement and Self-Verification
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Nursing Evaluation
Self-Evaluation Maintenance Model
Dysrhythmias V: Evaluating Dysrhythmias

